(:PROG)

May 05, 2022 06:30 am ET
Progenity Announces Successful Transfer of Liquid Biopsy Technologies
Progenity, Inc. (Nasdaq: PROG) today announced it has completed the divesture of a collection of novel, discovery-stage biochemical and bioinformatics technologies, including single-molecule detection, which are designed to enable next-generation...
May 03, 2022 09:00 am ET
Progenity to Report First Quarter Financial Results and Provide Corporate Update as Biora Therapeutics, Inc.
Progenity, Inc. (Nasdaq: PROG) today announced that it will report first quarter ended March 31, 2022 financial results on Tuesday, May 10, 2022 after the close of financial markets. Progenity’s management will host a webcast and conference call at...
Apr 25, 2022 09:00 am ET
Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s Ingestible Drug/Device Platforms
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced the appointment of Paul Shabram, MBA, as Senior Vice President, Technical Operations....
Apr 12, 2022 09:00 am ET
Progenity to Become Biora Therapeutics as it Completes Transformation
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that it will change its name to Biora Therapeutics, Inc. during the second quarter of...
Apr 06, 2022 09:00 am ET
Progenity Announces Two Poster Presentations at Controlled Release Society 2022
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced the acceptance of two abstracts presenting preclinical data on its systemic therapeutics...
Mar 28, 2022 04:01 pm ET
Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today provided a corporate update and reported financial results for the fourth quarter and full-year ended December 31, 2021. In the fourth quarter Progenity made important...
Mar 21, 2022 08:30 am ET
Thinking about buying stock in Mullen Automotive, Enservco, Bluejay Diagnostics, Integral Ad Science, or Progenity?
NEW YORK, March 21, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MULN, ENSV, BJDX, IAS, and PROG.
Mar 16, 2022 04:23 pm ET
Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that it will report financial results for the fourth quarter and full year ended...
Mar 10, 2022 09:00 am ET
Progenity Progresses its Drug Delivery System Clinical Device Performance Studies
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced progress with its clinical device performance study plan, evaluating the device function and safety of its Drug Delivery System (DDS) capsule. Progenity’s first...
Feb 28, 2022 09:00 am ET
Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced the acceptance of three abstracts on the treatment of IBD and microbiome sampling for...
Feb 22, 2022 09:00 am ET
Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO’22
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today shared two poster presentations that were presented during the 17th Congress of the European...
Feb 16, 2022 09:00 am ET
Progenity Shares Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today shared an oral presentation that was delivered by Dr. Bram Verstockt during the 34th edition of...
Jan 25, 2022 04:05 pm ET
Progenity Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional Patent
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the award of another new patent related to its single-molecule detection assay platform under development. The USPTO has issued U.S. Patent No. 11,230,731...
Jan 11, 2022 06:30 am ET
Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that patient data on indicators of efficacy in the treatment of gastrointestinal...
Jan 05, 2022 06:30 am ET
Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO’22
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that two presentations with patient data on indicators of efficacy in the treatment of...
Jan 03, 2022 06:30 am ET
Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that the company will participate in a pre-recorded presentation at the H.C....
Dec 20, 2021 04:05 pm ET
Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced it has successfully closed the business divestiture of its affiliate Avero Diagnostics...
Dec 02, 2021 06:30 am ET
Progenity Announces New Patent for Single-Molecule Detection Technology
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a new patent related to its single-molecule detection platform under development. The USPTO has...
Nov 23, 2021 06:30 am ET
Progenity Strengthens its Liquidity Position
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today provided an update on its strengthened liquidity position. “Over the last several months, we made great...
Nov 22, 2021 09:46 am ET
Thinking about buying stock in Camber Energy, Naked Brand, Progenity, Vale SA, or RLX Technology?
NEW YORK, Nov. 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CEI, NAKD, PROG, VALE, and RLX.
Nov 18, 2021 11:17 am ET
Thinking about buying stock in Lucid Group, Clover Health, Progenity, Tilray, or Vipshop Holdings?
NEW YORK, Nov. 18, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LCID, CLOV, PROG, TLRY, and VIPS.
Nov 17, 2021 07:37 am ET
Thinking about buying stock in 17 Education & Technology, Progenity, Canoo, Vir Biotechnology, or Zosano Pharma?
NEW YORK, Nov. 17, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for YQ, PROG, GOEV, VIR, and ZSAN.
Nov 16, 2021 07:30 am ET
Thinking about buying stock in Kezar Life Sciences, SCYNEXIS, Plby Group, Progenity, or Rackspace Technology?
NEW YORK, Nov. 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for KZR, SCYX, PLBY, PROG, and RXT.
Nov 15, 2021 06:30 am ET
Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in a pre-recorded fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, which will be available on the...
Nov 10, 2021 04:01 pm ET
Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today provided a corporate update and reported financial results for the third quarter ended September 30, 2021. During the third quarter, Progenity added four patents related to...
Nov 09, 2021 06:30 am ET
Progenity Appoints Adi Mohanty as Chief Executive Officer
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the appointment of Adi Mohanty as Chief Executive Officer of the company, effective November 8, 2021. Mr. Mohanty also joins the Progenity Board of Directors. “As...
Nov 04, 2021 06:30 am ET
Progenity Announces Appointment of Jill Howe to its Board of Directors
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced the appointment of Jill Howe to its board of directors effective November 3, 2021. Ms. Howe was also appointed chairperson of the Audit Committee and member of the...
Nov 03, 2021 07:30 am ET
Progenity to Report Third Quarter 2021 Financial Results and Provide Corporate Update
Progenity, Inc. (NASDAQ: PROG), an innovative biotechnology company, today announced that it will report third quarter 2021 financial results on Wednesday, November 10, 2021 after the close of financial markets. Progenity’s management will host a...
Oct 29, 2021 09:31 am ET
Thinking about buying stock in Pfizer, Phillips 66, Plug Power, Progenity, or Edesa Biotech?
NEW YORK, Oct. 29, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE, PSX, PLUG, PROG, and EDSA.
Oct 26, 2021 07:30 am ET
Progenity Reduces Outstanding Debt by $20.175 Million Through a Private Exchange of $20.175 Million of Its 7.25% Convertible Senior Notes Due 2025 for Shares of Common Stock
Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into privately negotiated agreements with certain non-affiliated holders of its existing 7.25% convertible senior notes due 2025...
Oct 25, 2021 09:31 am ET
Thinking about buying stock in AT&T, Tesla, Pfizer, Progenity, or Energous Corp?
NEW YORK, Oct. 25, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for T, TSLA, PFE, PROG, and WATT.
Oct 22, 2021 11:05 am ET
Thinking about buying stock in Creatd, Sundial Growers, Progenity, IZEA Worldwide, or Senseonics Holdings?
NEW YORK, Oct. 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CRTD, SNDL, PROG, IZEA, and SENS.
Oct 21, 2021 11:00 am ET
Thinking about buying stock in Xiaobai Maimai, Progenity, ContextLogic, Plug Power, or Skillz?
NEW YORK, Oct. 21, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HX, PROG, WISH, PLUG, and SKLZ.
Oct 20, 2021 10:55 am ET
Thinking about buying stock in Progenity, Ford, Tilray, LumiraDx, or Tencent Music Entertainment?
NEW YORK, Oct. 20, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PROG, F, TLRY, LMDX, and TME.
Oct 19, 2021 10:45 am ET
Thinking about buying stock in Progenity, Atea Pharmaceuticals, Peabody Energy, Adamis Pharmaceuticals, or Ion Geophysical?
NEW YORK, Oct. 19, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PROG, AVIR, BTU, ADMP, and IO.
Oct 19, 2021 07:30 am ET
Progenity to Participate in Crohn’s & Colitis Foundation’s Fourth Annual IBD Innovate Conference
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the fourth annual IBD Innovate Product Development for Crohn’s & Colitis virtual conference, hosted by the Crohn’s & Colitis...
Oct 18, 2021 11:00 am ET
Thinking about buying stock in Farmmi, Progenity, Ford, Virgin Galactic, or Lucid Group?
NEW YORK, Oct. 18, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FAMI, PROG, F, SPCE, and LCID.
Oct 15, 2021 10:45 am ET
Thinking about buying stock in CleanSpark, Virgin Galactic, Progenity, Up Fintech, or Waitr?
NEW YORK, Oct. 15, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLSK, SPCE, PROG, TIGR, and WTRH.
Oct 14, 2021 09:31 am ET
Thinking about buying stock in Hallador Energy, Progenity, Tata Motors, Live Oak Acquisition, or Talkspace?
NEW YORK, Oct. 14, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HNRG, PROG, TTM, LOKB, and TALK.
Oct 13, 2021 09:31 am ET
Thinking about buying stock in Progenity, Neurobo Pharmaceuticals, Vistra Corp, Plug Power, or Tata Motors?
NEW YORK, Oct. 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PROG, NRBO, VST, PLUG, and TTM.
Oct 13, 2021 07:30 am ET
Progenity Announces Several Patents Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Ingestible Therapeutics Technologies
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the United States Patent and Trademark Office (USPTO) has issued four patents related to its ingestible technologies for delivery of therapeutics via the...
Oct 12, 2021 10:50 am ET
Thinking about buying stock in Progenity, Farmmi, RR Donnelley & Sons, SoFi Technologies, or Voyager Therapeutics?
NEW YORK, Oct. 12, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PROG, FAMI, RRD, SOFI, and VYGR.
Oct 11, 2021 10:55 am ET
Thinking about buying stock in Camber Energy, NanoVibronix, Progenity, Marathon Oil, or Bit Digital?
NEW YORK, Oct. 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CEI, NAOV, PROG, MRO, and BTBT.
Oct 08, 2021 10:55 am ET
Thinking about buying stock in Ford Motor, Macquarie Infrastructure, Progenity, Agile Therapeutics, or Aehr Test Systems?
NEW YORK, Oct. 8, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for F, MIC, PROG, AGRX, and AEHR.
Oct 07, 2021 08:30 am ET
Thinking about buying stock in Tata Motors, New Fortress Energy, Arbutus Biopharma, US Well Services, or Progenity?
NEW YORK, Oct. 7, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TTM, NFE, ABUS, USWS, and PROG.
Oct 06, 2021 04:02 pm ET
Progenity Announces Closing of $20 Million Registered Direct Offering of Common Stock Priced at Premium to Market Under Nasdaq Rules
Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the closing of its previously announced registered direct offering of 13,333,334 shares of the Company's common stock, at a purchase price of $1.50...
Oct 06, 2021 08:30 am ET
Thinking about buying stock in Voyager Therapeutics, Aditxt, Agrify, Progenity, or Amplify Energy?
NEW YORK, Oct. 6, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VYGR, ADTX, AGFY, PROG, and AMPY.
Oct 05, 2021 09:31 am ET
Thinking about buying stock in Flux Power, Amplify Energy, Salem Media, Aethlon Medical, or Progenity?
NEW YORK, Oct. 5, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FLUX, AMPY, SALM, AEMD, and PROG.
Oct 04, 2021 01:40 pm ET
Progenity Announces $20 Million Registered Direct Offering of Common Stock Priced at Premium to Market Under Nasdaq Rules
Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into a definitive agreement with several institutional investors for the purchase and sale, in a registered direct offering...
Oct 04, 2021 10:45 am ET
Thinking about buying stock in Progenity, Camber Energy, Southwest Airlines, Marathon Oil, or Palantir Technologies?
NEW YORK, Oct. 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PROG, CEI, LUV, MRO, and PLTR.
Oct 01, 2021 08:30 am ET
Thinking about buying stock in US Well Services, Biomerica, Progenity, Bitfarms, or Hut 8 Mining?
NEW YORK, Oct. 1, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for USWS, BMRA, PROG, BITF, and HUT.
Sep 30, 2021 08:30 am ET
Thinking about buying stock in Enveric Biosciences, Dole, Virgin Galactic, Progenity, or Trevena?
NEW YORK, Sept. 30, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ENVB, DOLE, SPCE, PROG, and TRVN.
Sep 21, 2021 07:30 am ET
Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the 11th annual Partnership Opportunities in Drug Delivery (PODD) Conference, October 28-29, 2021 in Boston. Progenity’s Vice...
Sep 14, 2021 08:53 am ET
Thinking about buying stock in aTyr Pharma, Progenity, AzurRx BioPharma, Rekor Systems, or Akerna Corp?
NEW YORK, Sept. 14, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LIFE, PROG, AZRX, REKR, and KERN.
Sep 14, 2021 07:30 am ET
Progenity Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,112,403 for assessment of preeclampsia using assays for free and...
Sep 07, 2021 09:31 am ET
Thinking about buying stock in Pliant Therapeutics, Comstock Mining, Metromile, Progenity, or Paya Holdings?
NEW YORK, Sept. 7, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PLRX, LODE, MILE, PROG, and PAYA.
Sep 03, 2021 07:30 am ET
Progenity to Participate in Two Upcoming Investor Conferences
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in two upcoming virtual investor conferences: A pre-recorded presentation at H.C. Wainwright’s 23rd Annual Global Investment...
Aug 24, 2021 04:05 pm ET
Progenity Announces Closing of $40 Million Underwritten Public Offering
Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the closing of its previously announced underwritten public offering of 40,000,000 shares of its common stock and warrants to purchase up to...
Aug 20, 2021 10:45 am ET
Thinking about buying stock in Sonnet BioTherapeutics, Progenity, Hexo Corp, SunLink Health Systems, or Endo International?
NEW YORK, Aug. 20, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SONN, PROG, HEXO, SSY, and ENDP.
Aug 19, 2021 10:20 pm ET
Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants
Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the pricing of its previously announced underwritten public offering of 40,000,000 shares of its common stock and warrants to purchase up to...
Aug 19, 2021 04:05 pm ET
Progenity Announces Proposed Underwritten Public Offering of Common Stock and Warrants
Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock and warrants to purchase shares of its common...
Aug 12, 2021 04:01 pm ET
Progenity Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today provided a corporate update and reported financial results for the second quarter ended June 30, 2021. In...
Aug 05, 2021 04:05 pm ET
Progenity to Report Second Quarter 2021 Financial Results and Provide Corporate Update
Progenity, Inc. (NASDAQ: PROG), an innovative biotechnology company, today announced that it will report second quarter 2021 financial results on Thursday, August 12, 2021 after the close of financial markets. Progenity’s management will host a...
Jul 31, 2021 09:06 am ET
(PROG) Long Term Investor Alert: Johnson Fistel Investigates Progenity; Should Management be Held Accountable for Investors Losses?
Johnson Fistel, LLP is investigating potential claims on behalf of Progenity, Inc. (NASDAQ: PROG) against certain current and former officers and directors.  In June 2020, Progenity completed its initial public offering (the "IPO"), in which it...
Jul 29, 2021 07:30 am ET
Progenity Announces Successful Completion of Clinical Validation Study and Achievement of the Primary Endpoint for its Preeclampsia Rule-Out Test
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today successful completion of the validation study for its Preecludia™ rule-out test for preeclampsia and achievement of the primary endpoint of the study protocol....
Jun 30, 2021 07:30 am ET
Progenity Announces Appointment of Surbhi Sarna to its Board of Directors
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced the appointment of Surbhi Sarna to its board of directors effective July 1, 2021. Ms. Surbhi’s medical device experience and her focus on development of strategic...
Jun 25, 2021 10:50 pm ET
PROGENITY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Progenity, Inc. - PROG
NEW ORLEANS, June 25, 2021 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues its investigation into Progenity, Inc. (NasdaqGM: PROG).  
Jun 19, 2021 03:00 am ET
(PROG) Long Term Investor Alert: Johnson Fistel Investigates Progenity; Should Management be Held Accountable for Investors Losses?
Johnson Fistel, LLP is investigating potential claims on behalf of Progenity, Inc. (NASDAQ: PROG) against certain current and former officers and directors.  In June 2020, Progenity completed its initial public offering (the "IPO"), in...
Jun 17, 2021 07:30 am ET
Progenity Establishes Inflammatory Bowel Disease Clinical Advisory Board
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the formation of its Inflammatory Bowel Disease Clinical Advisory Board. The advisory board includes respected researchers and clinicians who are thought leaders...
Jun 15, 2021 07:30 am ET
Progenity to Participate in the Raymond James 2021 Human Health Innovation Conference
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that Harry Stylli, PhD, CEO, chairman of the board, and co-founder of Progenity, will participate in a fireside chat at the virtual Raymond James 2021 Human Health...
Jun 11, 2021 10:50 pm ET
PROGENITY INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Progenity, Inc. - PROG
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Progenity, Inc. (NasdaqGM: PROG).
Jun 10, 2021 07:30 am ET
Progenity Announces $40 Million Private Placement
Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into a definitive securities purchase agreement with two leading healthcare-focused investment funds for the sale of units...
Jun 02, 2021 07:00 am ET
Progenity Launches Strategic Transformation into Biotech Company, Eliminating Costs of Progenity Genetics Lab and Focusing on Robust, Innovative R&D Pipeline
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced a transformation strategy that will focus the company primarily on its robust R&D pipeline and better position the business for future growth. To achieve this...
May 26, 2021 07:30 am ET
Progenity Provides Results from Key Study for Its Targeted Therapeutics Program
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced results from a further study for the company’s Targeted Therapeutics program. The study evaluated delivery of Progenity’s PGN-001 (adalimumab) drug substance...
May 25, 2021 07:30 am ET
Sean Lavin, MD, Joins Progenity as Vice President, Business Development, Strategy, and Investor Relations
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the appointment of Sean Lavin, M.D. as Vice President, Business Development, Strategy, and Investor Relations. In this advisory role, Dr. Lavin will work with...
May 24, 2021 07:30 am ET
Progenity Announces Poster Presentations at Digestive Disease Week 2021
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the presentation of two posters related to the company’s Targeted Therapeutics program presented at the 2021 Digestive Disease Week® (DDW) Virtual Event. The...
May 21, 2021 07:30 am ET
Progenity Joins Global Call to Raise Awareness of Preeclampsia in Pregnancy on World Preeclampsia Day – May 22nd
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing products in women’s health, joins the global call to raise awareness of preeclampsia in pregnancy...
May 13, 2021 04:03 pm ET
Progenity Provides Corporate Update and Reports First Quarter 2021 Financial Results
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today provided a corporate update and reported financial results for the first quarter...
May 12, 2021 07:29 am ET
Progenity Provides Preliminary Results from Key Studies for its Targeted Therapeutics Program
Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced preliminary results, subject to final audited study reports by its contract research organization (CRO), from two key studies for the Company’s Targeted...
May 11, 2021 07:30 am ET
Progenity Receives Funding from Crohn’s & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing products, announced today that it has received funding from the Crohn’s & Colitis Foundation’s IBD...
May 06, 2021 07:30 am ET
Progenity to Report First Quarter 2021 Financial Results and Provide Corporate Update
Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it will report first quarter 2021 financial results on Thursday,...
May 05, 2021 07:30 am ET
Progenity Provides Key Update Regarding its Preecludia™ Test for Preeclampsia
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced another key update regarding its Preecludia preeclampsia rule-out...
May 04, 2021 07:30 am ET
Survey Reveals Pregnant Women Lack Awareness About Preeclampsia, the #2 Cause of Maternal Death
May is Preeclampsia Awareness Month, and a recent survey is underscoring a stark need for more education around the second-most common cause of maternal mortality in the United States. The survey of nearly 800 women, including expectant mothers,...
Apr 30, 2021 04:04 pm ET
Progenity Presents Key Verification Study Data for Preecludia™ Preeclampsia Rule-out Test at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced new data from its Preecludia preeclampsia rule-out test verification...
Apr 26, 2021 07:30 am ET
Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that two abstracts related to Progenity’s ingestible drug delivery...
Apr 08, 2021 07:30 am ET
Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing products in women’s health, will be presenting verification study data for its Preecludia™ rule-out...
Apr 06, 2021 07:30 am ET
Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing products, today announced an agreement with Ionis Pharmaceuticals, the leader in RNA-targeted...
Mar 18, 2021 04:05 pm ET
Progenity Provides Corporate Updates and Reports Fourth Quarter and Full-Year 2020 Financial Results
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today provided corporate updates and reported financial results for the fourth quarter...
Mar 12, 2021 07:30 am ET
Progenity to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it will report fourth quarter and full year 2020 financial...
Mar 03, 2021 02:10 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
NEW YORK, March 3, 2021 /CNW/ -- Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc.  ("Silk Road" or the "Company") (NASDAQ: PROG).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Feb 23, 2021 07:45 am ET
Progenity Announces $25 Million Private Placement
Progenity, Inc. (“Progenity”) (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it has entered into a definitive securities...
Feb 18, 2021 11:25 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
NEW YORK, Feb. 19, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc.  ("Silk Road" or the "Company") (NASDAQ: PROG).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Feb 17, 2021 07:30 am ET
Progenity Initiates Safety and Tolerability Study of its Smart Capsule-Based Oral Drug Delivery System for GI Diseases
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing products, today announced the initiation of a clinical study for their Drug Delivery System (DDS)...
Feb 12, 2021 07:30 am ET
SMFM Conference and Publications Highlight the Challenges and Complexities of Diagnosing and Managing Preeclampsia
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, applauds the continuing focus of the Society for Maternal-Fetal Medicine (SMFM) on the...
Feb 10, 2021 07:30 am ET
Progenity to Participate in Two Upcoming Investor Conferences
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that Harry Stylli, Ph.D., CEO, chairman of the board, and co-founder...
Feb 08, 2021 06:00 am ET
PROG Holdings, Inc. Announces Fourth Quarter 2020 Earnings Call and Webcast
SALT LAKE CITY, Feb. 8, 2021 /PRNewswire/ -- PROG Holdings, Inc. (NYSE-PRG), a leading provider of lease-purchase solutions, will host a conference call and webcast on Thursday, February 25, 2021, at 8:30 a.m. Eastern Time to discuss its fourth quarter 2020 financial results scheduled for release before the market opens on that day.
Jan 20, 2021 07:30 am ET
Progenity Reaches Two Million Test Milestone
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, has reported the completion of two million diagnostic tests by its CLIA-certified and...
Jan 13, 2021 04:05 pm ET
Progenity Provides Financial Guidance for Full-year 2021
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today provided 2021 full-year financial guidance. “The year 2020 proved to be a...
Jan 05, 2021 07:30 am ET
Progenity to Present at the 2021 ICR Conference
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced its participation in the 2021 ICR Conference. Harry Stylli, Ph.D.,...
Dec 17, 2020 07:30 am ET
Progenity Expands Availability of COVID-19 PCR Testing Services Across United States
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products in women’s health, today announced that it is expanding the availability of COVID-19...
Dec 08, 2020 07:31 am ET
Progenity Announces Closing of the Convertible Senior Notes Offering and Partial Exercise of the Initial Purchaser’s Option to Purchase Additional Notes
Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced the closing of its offering of $85,525,000 aggregate principal amount...
Dec 08, 2020 07:30 am ET
Progenity Announces Closing of Public Offering of Common Stock
Progenity, Inc. (“Progenity”) (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced the closing of its previously announced underwritten...
Dec 02, 2020 11:51 pm ET
Progenity, Inc. Prices $75.0 Million Convertible Senior Notes Offering
Progenity, Inc. (NASDAQ: PROG) today announced the pricing of its offering of $75.0 million aggregate principal amount of 7.25% convertible senior notes due 2025 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule...
Dec 02, 2020 11:50 pm ET
Progenity Announces Pricing of Public Offering of Common Stock
Progenity, Inc. (“Progenity”) (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced the pricing of its previously announced underwritten...
Nov 30, 2020 09:38 pm ET
Progenity Announces Proposed Convertible Senior Notes Offering
Progenity, Inc. (NASDAQ: PROG) today announced its intention to offer, subject to market and other conditions, $75 million aggregate principal amount of convertible senior notes due 2025 (the “notes”) in a private offering to qualified...
Nov 30, 2020 09:38 pm ET
Progenity Announces Proposed Public Offering of Common Stock
Progenity, Inc. (“Progenity”) (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it has commenced an underwritten public offering of...
Nov 20, 2020 07:30 am ET
New Test for Triaging Preeclampsia Passes Key Development Milestone: Progenity Releases Prospective Clinical Verification Data for its Preecludia™ Test
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products in women’s health is pleased to announce the company has reported clinical verification...
Nov 17, 2020 07:30 am ET
Progenity to Present at 2020 San Antonio Breast Cancer Virtual Symposium
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, will be presenting at the San Antonio Breast Cancer Virtual Symposium (SABCS) set to...
Nov 16, 2020 07:30 am ET
Progenity to Participate in the 32nd Annual Piper Sandler Healthcare Conference
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that Harry Stylli, Ph.D., CEO, chairman of the board, and co-founder...
Nov 13, 2020 07:30 am ET
Progenity to Host Preeclampsia Virtual R&D Day on November 20, 2020
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it will host a Preeclampsia Virtual R&D Day on November 20, 2020...
Nov 09, 2020 04:05 pm ET
Progenity Provides Corporate Updates and Reports Third Quarter 2020 Financial Results
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today provided corporate updates and reported financial results for the third quarter...
Nov 06, 2020 07:30 am ET
Progenity Announces Encouraging Preclinical Data Supporting the Potential of the Company’s Oral Drug Delivery System in Targeting the Colon
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, is pleased to announce positive preliminary preclinical data regarding the performance...
Nov 03, 2020 08:42 am ET
Progenity to Report Third Quarter 2020 Financial Results and Provide Corporate Update
Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it will report third quarter 2020 financial results on Monday,...
Oct 29, 2020 07:30 am ET
Progenity Announces Successful Achievement of its Preeclampsia Test Analytical Verification Milestone
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced a key achievement in the verification of its preeclampsia rule-out...
Oct 27, 2020 07:30 am ET
Progenity Presents Data from Award-Winning Abstract on Novel Ingestible Lab-in-a-Capsule at American College of Gastroenterology (ACG) 2020 Virtual Annual Meeting
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products and innovation in the field of gastrointestinal precision medicine, is pleased to...
Oct 26, 2020 08:36 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Oct 23, 2020 12:15 pm ET
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Progenity, Inc. (PROG)
The Law Offices of Frank R. Cruz reminds investors of the upcoming October 27, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ:
Oct 23, 2020 11:00 am ET
PROG Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Progenity, Inc. Investors of Class Action and Lead Plaintiff Deadline: October 27, 2020
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Progenity, Inc. ("Progenity" or "the Company") (NASDAQ: PROG) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Progenity common stock pursuant and/or traceable to the registration statement, as amended (the "Registration Statement"), issued in connection with Progenity’s June 2020 initial public offering ("IPO"). Such investors are encouraged to join this case by visiting the firm’s site:
Oct 21, 2020 07:03 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Oct 21, 2020 10:00 am ET
BAK, FSLY & PROG Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Upcoming Lead Plaintiff Deadlines
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Oct 20, 2020 05:00 pm ET
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Progenity, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of investors that...
Oct 20, 2020 11:00 am ET
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Progenity, Inc. (PROG)
BENSALEM, Pa., Oct. 20, 2020 /PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming October 27, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Progenity, Inc. ("Progenity" or the "Company") (NASDAQ: PROG) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company's initial public offering ("IPO") conducted in June 2020.
Oct 20, 2020 09:09 am ET
PROG INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors That Only 7 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Progenity, Inc.
NEW YORK, Oct. 20, 2020 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Progenity, Inc. ("Progenity" or the "Company") (NASDAQ: PROG) in the United States between June 19, 2020 and August 28, 2020 (the "Class Period"). The lawsuit filed in the United States District Court for the Southern District of California alleges violations of the Securities Act of 1933.
Oct 19, 2020 12:18 pm ET
DEADLINE ALERT for BAK and PROG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 17, 2020 06:48 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
NEW YORK, Oct. 17, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. ("Progenity" or the "Company") (NASDAQ: PROG).  Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980.
Oct 16, 2020 08:00 pm ET
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Progenity, Inc. Investors of Important October 27 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm –
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Progenity, Inc. (NASDAQ: PROG) pursuant and/or traceable to the Company’s initial public offering conducted in June 2020 (the “IPO”) of the important October...
Oct 16, 2020 12:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Progenity, Inc. (PROG)
LOS ANGELES, Oct. 16, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming October 27, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Progenity, Inc. ("Progenity" or the "Company") (NASDAQ: PROG) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company's initial public offering ("IPO") conducted in June 2020.  
Oct 15, 2020 01:00 pm ET
BAK, FSLY & PROG Class Action Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Upcoming Lead Plaintiff Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Oct 15, 2020 11:30 am ET
DEADLINE ALERT for BAK, PROG, FENC, POR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 14, 2020 02:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Braskem, Fastly, Progenity, and Ultra Petroleum and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Braskem S.A. (NYSE: BAK), Fastly, Inc. (NYSE: FSLY), Progenity, Inc. (NASDAQ:...
Oct 13, 2020 11:00 am ET
DEADLINE ALERT for BAK and PROG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 13, 2020 10:11 am ET
PROG SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Progenity, Inc.
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities...
Oct 13, 2020 09:00 am ET
Progenity, Inc. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of shareholders OF Progenity, Inc. In the Uni
NEW YORK and SAN DIEGO, Oct. 13, 2020 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") announces that a federal securities class action lawsuit has been filed against Progenity, Inc. ("Progenity" or the "Company") (NASDAQ: PROG) in the United States District Court for the Southern District of California on behalf of persons and entities that purchased or otherwise acquired Progenity, Inc. common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company's initial public offering ("IPO") conducted in June 2020.
Oct 13, 2020 08:00 am ET
LAWSUITS FOR SECURITIES VIOLATIONS FILED AGAINST PROG, POR, AND GOCO: Block & Leviton LLP Reminds Investors of Class Actions for Violations of the Federal Securities Laws
Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that securities class actions have been filed against Progenity, Inc. (NASDAQ: PROG), Portland General Electric Company (NYSE: POR), and GoHealth,...
Oct 12, 2020 09:57 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Oct 12, 2020 12:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Progenity, Inc. (PROG)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 27, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Progenity, Inc. (“Progenity” or the...
Oct 09, 2020 12:13 pm ET
ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds Progenity, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – PROG
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Progenity, Inc. (NASDAQ: PROG) pursuant and/or traceable to the Company’s initial public offering conducted in June 2020 (the “IPO”) of the important October 27, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Progenity investors under the federal securities laws.
Oct 09, 2020 07:30 am ET
Progenity to Present Precision Medicine Abstracts at American College of Gastroenterology (ACG) Virtual Annual Meeting in October
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, is pleased to announce that two abstracts related to Progenity’s ingestible...
Oct 07, 2020 04:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Blink Charging, Braskem, Fastly, and Progenity and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Blink Charging Company (NASDAQ: BLNK), Braskem S.A. (NYSE: BAK), Fastly, Inc....
Oct 07, 2020 12:30 pm ET
DEADLINE ALERT for BAK, PROG, FENC, POR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 07, 2020 10:00 am ET
PROG Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Progenity, Inc. Investors of Class Action and Lead Plaintiff Deadline: October 27, 2020
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Progenity, Inc. ("Progenity" or "the Company") (NASDAQ: PROG) and certain of its officers, on behalf of shareholders...
Oct 06, 2020 06:30 pm ET
ROSEN, NATIONAL TRIAL LAWYERS, Reminds Progenity, Inc. Investors of Important October 27 Deadline in Securities Class Action; Encourages Investors with Losses In Excess of $100K to Contact Firm – PROG
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Progenity, Inc. (NASDAQ: PROG) pursuant and/or traceable to the Company’s initial public offering conducted in June 2020 (the “IPO”) of the important October...
Oct 06, 2020 12:00 pm ET
DEADLINE ALERT for BAK and PROG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Oct 06, 2020 08:00 am ET
LAWSUITS FOR SECURITIES VIOLATIONS FILED AGAINST PROG, POR, AND GOCO: Block & Leviton LLP Reminds Investors of Class Actions for Violations of the Federal Securities Laws
Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that securities class actions have been filed against Progenity, Inc. (NASDAQ: PROG), Portland General Electric Company (NYSE: POR), and GoHealth,...
Oct 05, 2020 12:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Progenity, Inc. (PROG)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 27, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Progenity, Inc. (“Progenity” or the...
Oct 01, 2020 09:57 am ET
PROG SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Progenity, Inc.
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities of Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG) in the United States between June 19, 2020 and August 28, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Southern District of California alleges violations of the Securities Act of 1933.
Oct 01, 2020 07:30 am ET
Progenity Supports the Preeclampsia Foundation Call to Action to Accelerate Development and Adoption of Biomarker Tests for Preeclampsia
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced support for the Preeclampsia Foundation’s recent call to action...
Sep 30, 2020 05:50 pm ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Progenity, Inc. and Encourages Investors to Contact the Firm Before October 27, 2020
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ:
Sep 30, 2020 05:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Braskem, Fastly, Progenity, and Ultra Petroleum and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Braskem S.A. (NYSE: BAK), Fastly, Inc. (NYSE: FSLY), Progenity, Inc. (NASDAQ:...
Sep 30, 2020 11:30 am ET
DEADLINE ALERT for BAK, PROG, FENC, POR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 29, 2020 11:45 am ET
DEADLINE ALERT for BAK and PROG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 27, 2020 02:03 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Sep 25, 2020 06:45 pm ET
ROSEN, TRUSTED AND LEADING INVESTOR CONSEL, Reminds Progenity, Inc. Investors of Important October 27 Deadline in Securities Class Action; Encourages Investors with Losses In Excess of $100K to Contac
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Progenity, Inc. (NASDAQ: PROG) pursuant and/or traceable to the Company’s initial public offering conducted in June 2020 (the “IPO”) of the important October...
Sep 25, 2020 11:30 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Progenity, Inc. (PROG)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 27, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ:...
Sep 24, 2020 11:00 am ET
DEADLINE ALERT for BAK and PROG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 23, 2020 05:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Blink Charging, Braskem, Fastly, and Progenity and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Blink Charging Company (NASDAQ: BLNK), Braskem S.A. (NYSE: BAK), Fastly, Inc....
Sep 23, 2020 12:30 pm ET
DEADLINE ALERT for BAK, PROG, FENC, POR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 23, 2020 08:00 am ET
LAWSUITS FOR SECURITIES VIOLATIONS FILED AGAINST PROG AND COTY: Block & Leviton LLP Reminds Investors of Class Actions for Violations of the Federal Securities Laws
Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that securities class actions have been filed against Progenity, Inc. (NASDAQ: PROG) and Coty Inc. (NYSE: COTY). Shareholders interested in serving...
Sep 22, 2020 11:00 am ET
PROG Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Progenity, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: October 27, 2020
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Progenity, Inc. ("Progenity" or "the Company") (NASDAQ: PROG) and certain of its officers, on behalf of shareholders...
Sep 21, 2020 08:37 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Sep 18, 2020 07:30 am ET
Progenity Announces Addition to Russell 2000® Index
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that it will be added to the Russell 2000®  Index, effective when the...
Sep 17, 2020 12:00 pm ET
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Progenity, Inc. Investors of Important Deadline in Securities Class Action – PROG
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Progenity, Inc. (NASDAQ: PROG) pursuant and/or traceable to the Company’s initial public offering conducted in June 2020 (the “IPO”) of the important October 27, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Progenity investors under the federal securities laws.
Sep 17, 2020 11:15 am ET
DEADLINE ALERT for BAK and PROG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 16, 2020 09:36 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG
Pomerantz LLP is investigating claims on behalf of investors of Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Sep 16, 2020 06:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Braskem, Fastly, Progenity, and Ultra Petroleum and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Braskem S.A. (NYSE: BAK), Fastly, Inc. (NYSE: FSLY), Progenity, Inc. (NASDAQ:...
Sep 16, 2020 12:30 pm ET
DEADLINE ALERT for NSP, ERII, BAK, PROG: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 15, 2020 02:37 pm ET
PROGENITY, INC. (NASDAQ: PROG) INVESTOR NOTICE: Abraham, Fruchter & Twersky, LLP Files Securities Class Action Lawsuit
Abraham, Fruchter & Twersky, LLP (www.aftlaw.com) announces that it has filed a class action lawsuit against Progenity, Inc. (“PROGENITY”) (NASDAQ: PROG) on behalf of investors who purchased PROGENITY stock pursuant and/or traceable to PROGENITY’s...
Sep 15, 2020 10:06 am ET
PROG SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Progenity, Inc.
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the securities...
Sep 15, 2020 08:00 am ET
LAWSUITS FOR SECURITIES VIOLATIONS FILED AGAINST PROG AND COTY: Block & Leviton LLP Reminds Investors of Class Actions for Violations of the Federal Securities Laws
Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that securities class actions have been filed against Progenity, Inc. (NASDAQ: PROG) and Coty Inc. (NYSE: COTY). Shareholders interested in serving...
Sep 11, 2020 05:00 pm ET
ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Progenity, Inc. Investors of Important Deadline in Securities Class Action – PROG
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Progenity, Inc. (NASDAQ: PROG) pursuant and/or traceable to the Company’s initial public offering conducted in June 2020 (the “IPO”) of the important October 27, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Progenity investors under the federal securities laws.
Sep 10, 2020 11:00 am ET
DEADLINE ALERT for BAK and PROG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 10, 2020 10:00 am ET
PROG Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Progenity, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: October 27, 2020
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Progenity, Inc. ("Progenity" or "the Company") (NASDAQ: PROG) and certain of its officers, on behalf of shareholders...
Sep 09, 2020 08:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Braskem, Fastly, Progenity, and Ultra Petroleum and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Braskem S.A. (NYSE: BAK), Fastly, Inc. (NYSE: FSLY), Progenity, Inc. (NASDAQ:...
Sep 08, 2020 08:30 pm ET
ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Progenity, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm – PROG
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Progenity, Inc. (NASDAQ: PROG) pursuant and/or traceable to the Company’s initial public offering...
Sep 04, 2020 12:30 pm ET
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Progenity, Inc. (PROG)
Law Offices of Howard G. Smith reminds investors of the upcoming October 27, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG) common stock pursuant and/or traceable to the Registration Statem
Sep 04, 2020 11:00 am ET
PROG Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Progenity, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: October 27, 2020
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Progenity, Inc. ("Progenity" or "the Company") (NASDAQ: PROG) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Progenity common stock pursuant and/or traceable to the registration statement, as amended (the "Registration Statement"), issued in connection with Progenity’s June 2020 initial public offering ("IPO"). Such investors are encouraged to join this case by visiting the firm’s site:
Sep 04, 2020 10:00 am ET
DEADLINE ALERT for BAK and PROG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 03, 2020 10:00 am ET
PROG Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Progenity, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: October 27, 2020
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Progenity, Inc. ("Progenity" or "the Company") (NASDAQ: PROG) and certain of its officers, on behalf of shareholders...
Sep 03, 2020 09:00 am ET
SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of NGHC, GOCO, PSTX, and PROG; Shareholders are Encouraged to Contact the Firm
If you own any of the above stocks and would like to discuss your legal rights, please email [email protected] or call (619) 400-4966.            National General Holdings Corp. (NASDAQ:NGHC)  The investigation of National General Holdings...
Sep 02, 2020 02:32 pm ET
Robbins LLP Announces Progenity, Inc. (PROG) Sued for Misleading Shareholders
Shareholder rights law firm Robbins LLP announces that a class action complaint was filed against Progenity, Inc. (NASDAQ: PROG) on behalf of shareholders who acquired Progenity, Inc. shares pursuant to the Company's June 2020 initial public offering ("IPO"). Progenity is a biotechnology company that provides in vitro mole
Sep 02, 2020 07:30 am ET
Progenity to Participate in Two Upcoming Investor Conferences
Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced that Harry Stylli, Ph.D., CEO, chairman of the board, and co-founder...
Sep 01, 2020 07:00 pm ET
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Progenity, Inc.
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ:
Sep 01, 2020 04:03 pm ET
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Progenity, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Progenity, Inc. (“Progenity” or “the Company”) (NASDAQ:
Sep 01, 2020 03:27 pm ET
Progenity, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Lawsuit Has Been Filed on Behalf of Shareholders of Progenity, Inc. in the Unite
Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”) announces that a federal securities class action lawsuit has been filed against Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG) in the United States District Court for the...
Sep 01, 2020 01:44 pm ET
Portnoy Law: Lawsuit Filed On Behalf of Progenity, Inc. Investors
The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Progenity, Inc. ("Progenity" or "the Company") (NASDAQ: PROG) investors that acquired securities in connection with Progenity’s June 2020 initial public...
Sep 01, 2020 12:59 pm ET
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Progenity, Inc. (PROG)
Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG) in the United States District Court for the Southern District of California on behalf of persons...
Aug 31, 2020 07:05 pm ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Progenity, Inc. (PROG) Investors
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Progenity, Inc. ("Progenity" or the "Company") (NASDAQ:
Aug 31, 2020 07:00 pm ET
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Progenity, Inc. (PROG) Investors
Glancy Prongay & Murray LLP (“GPM”), a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased Progenity, Inc. ("Progenity" or the "Company") (NASDAQ:
Aug 31, 2020 03:25 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Progenity, Inc. (PROG) Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Progenity, Inc. ("Progenity" or the "Company") (NASDAQ: PROG) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s initial public offering (“IP
Aug 31, 2020 02:52 pm ET
PROG SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit has been Filed Against Progenity, Inc.
Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the securities of Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG) in the United States between June 19, 2020 and August 28, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Southern District of California alleges violations of the Securities Act of 1933.
Aug 31, 2020 12:51 pm ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Progenity, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Progenity, Inc. (“Progenity” or “the Company”) (NASDAQ:
Aug 31, 2020 11:20 am ET
PROGENITY ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Progenity, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of investors that purchased...
Aug 31, 2020 10:27 am ET
EQUITY ALERT: ROSEN, A LEADING NATIONAL FIRM, Announces Filing of Securities Class Action Lawsuit Against Progenity, Inc. – PROG
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Progenity, Inc. (NASDAQ: PROG) pursuant and/or traceable to the Company’s initial public offering conducted in June 2020 (the “IPO” or “Offering”). The lawsuit seeks to recover damages for Progenity investors under the federal securities laws.
Aug 31, 2020 08:17 am ET
CASE FILED: Block & Leviton LLP Announces the Filing of a Lawsuit for Violation of the Federal Securities Laws Against Progenity, Inc.; Investors Who Lost Money Should Contact the Firm
Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that a securities class action has been filed against Progenity, Inc. (NASDAQ: PROG) and certain of its executives. Investors who purchased Progenity...
Aug 28, 2020 08:00 pm ET
Aug 28, 2020 04:00 pm ET
PROGENITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progenity, Inc. on Behalf of Progenity Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Progenity, Inc. (NASDAQ: PROG) on behalf of Progenity stockholders. Our investigation concerns whether Progenity has...
Aug 27, 2020 06:00 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Progenity, Inc. (PROG) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ:
Aug 27, 2020 04:00 pm ET
The Law Offices of Frank R. Cruz Announces Investigation of Progenity, Inc. (PROG) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation on behalf of Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ:
Aug 27, 2020 02:00 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Progenity, Inc. (PROG) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Progenity, Inc. (“Progenity” or the “Company”) (NASDAQ: PROG) investors concerning the Company’s possible violations of federal securities laws.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.